147 related articles for article (PubMed ID: 11908637)
1. Cancer prevention by bovine lactoferrin and underlying mechanisms--a review of experimental and clinical studies.
Tsuda H; Sekine K; Fujita K; Ligo M
Biochem Cell Biol; 2002; 80(1):131-6. PubMed ID: 11908637
[TBL] [Abstract][Full Text] [Related]
2. Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals.
Tsuda H; Sekine K; Takasuka N; Toriyama-Baba H; Iigo M
Biofactors; 2000; 12(1-4):83-8. PubMed ID: 11216510
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice.
Iigo M; Kuhara T; Ushida Y; Sekine K; Moore MA; Tsuda H
Clin Exp Metastasis; 1999 Feb; 17(1):35-40. PubMed ID: 10390145
[TBL] [Abstract][Full Text] [Related]
4. Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin.
Wang WP; Iigo M; Sato J; Sekine K; Adachi I; Tsuda H
Jpn J Cancer Res; 2000 Oct; 91(10):1022-7. PubMed ID: 11050473
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats.
Fujita K; Ohnishi T; Sekine K; Iigo M; Tsuda H
Jpn J Cancer Res; 2002 Jun; 93(6):616-25. PubMed ID: 12079509
[TBL] [Abstract][Full Text] [Related]
6. Orally administered bovine lactoferrin induces caspase-1 and interleukin-18 in the mouse intestinal mucosa: a possible explanation for inhibition of carcinogenesis and metastasis.
Iigo M; Shimamura M; Matsuda E; Fujita K; Nomoto H; Satoh J; Kojima S; Alexander DB; Moore MA; Tsuda H
Cytokine; 2004 Jan; 25(1):36-44. PubMed ID: 14687584
[TBL] [Abstract][Full Text] [Related]
7. Anticarcinogenesis pathways activated by bovine lactoferrin in the murine small intestine.
Iigo M; Alexander DB; Long N; Xu J; Fukamachi K; Futakuchi M; Takase M; Tsuda H
Biochimie; 2009 Jan; 91(1):86-101. PubMed ID: 18634843
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats.
Tanaka T; Kawabata K; Kohno H; Honjo S; Murakami M; Ota T; Tsuda H
Jpn J Cancer Res; 2000 Jan; 91(1):25-33. PubMed ID: 10744041
[TBL] [Abstract][Full Text] [Related]
9. Bovine lactoferrin: benefits and mechanism of action against infections.
Yamauchi K; Wakabayashi H; Shin K; Takase M
Biochem Cell Biol; 2006 Jun; 84(3):291-6. PubMed ID: 16936799
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of lactoferrin increases NK cell activity in mice via increased production of IL-18 and type I IFN in the small intestine.
Kuhara T; Yamauchi K; Tamura Y; Okamura H
J Interferon Cytokine Res; 2006 Jul; 26(7):489-99. PubMed ID: 16800788
[TBL] [Abstract][Full Text] [Related]
11. Prevention of carcinogenesis and cancer metastasis by bovine lactoferrin.
Tsuda H; Fukamachi K; Xu J; Sekine K; Ohkubo S; Takasuka N; Iigo M
Proc Jpn Acad Ser B Phys Biol Sci; 2006 Nov; 82(7):208-15. PubMed ID: 25792784
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats.
Sekine K; Watanabe E; Nakamura J; Takasuka N; Kim DJ; Asamoto M; Krutovskikh V; Baba-Toriyama H; Ota T; Moore MA; Masuda M; Sugimoto H; Nishino H; Kakizoe T; Tsuda H
Jpn J Cancer Res; 1997 Jun; 88(6):523-6. PubMed ID: 9263527
[TBL] [Abstract][Full Text] [Related]
13. Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium.
Kuhara T; Iigo M; Itoh T; Ushida Y; Sekine K; Terada N; Okamura H; Tsuda H
Nutr Cancer; 2000; 38(2):192-9. PubMed ID: 11525597
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of azoxymethane initiated colon tumor and aberrant crypt foci development by bovine lactoferrin administration in F344 rats.
Tsuda H; Sekine K; Nakamura J; Ushida Y; Kuhara T; Takasuka N; Kim DJ; Asamoto M; Baba-Toriyama H; Moore MA; Nishino H; Kakizoe T
Adv Exp Med Biol; 1998; 443():273-84. PubMed ID: 9781370
[TBL] [Abstract][Full Text] [Related]
15. Bovine lactoferrin inhibits tumor-induced angiogenesis.
Shimamura M; Yamamoto Y; Ashino H; Oikawa T; Hazato T; Tsuda H; Iigo M
Int J Cancer; 2004 Aug; 111(1):111-6. PubMed ID: 15185351
[TBL] [Abstract][Full Text] [Related]
16. Dose-response trial of lactoferrin in patients with chronic hepatitis C.
Okada S; Tanaka K; Sato T; Ueno H; Saito S; Okusaka T; Sato K; Yamamoto S; Kakizoe T
Jpn J Cancer Res; 2002 Sep; 93(9):1063-9. PubMed ID: 12359061
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.
Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane.
Sekine K; Ushida Y; Kuhara T; Iigo M; Baba-Toriyama H; Moore MA; Murakoshi M; Satomi Y; Nishino H; Kakizoe T; Tsuda H
Cancer Lett; 1997 Dec; 121(2):211-6. PubMed ID: 9570361
[TBL] [Abstract][Full Text] [Related]
19. Bovine lactoferrin inhibits lung cancer growth through suppression of both inflammation and expression of vascular endothelial growth factor.
Tung YT; Chen HL; Yen CC; Lee PY; Tsai HC; Lin MF; Chen CM
J Dairy Sci; 2013 Apr; 96(4):2095-2106. PubMed ID: 23462173
[TBL] [Abstract][Full Text] [Related]
20. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.
Ikeda M; Nozaki A; Sugiyama K; Tanaka T; Naganuma A; Tanaka K; Sekihara H; Shimotohno K; Saito M; Kato N
Virus Res; 2000 Jan; 66(1):51-63. PubMed ID: 10653917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
